Osaic Holdings’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.6K | Sell |
435
-1,829
| -81% | -$36.2K | ﹤0.01% | 5856 |
|
|
2025
Q1 | $56.3K | Buy |
2,264
+1,117
| +97% | +$27.8K | ﹤0.01% | 4611 |
|
|
2024
Q4 | $21.6K | Buy |
1,147
+407
| +55% | +$7.67K | ﹤0.01% | 5254 |
|
|
2024
Q3 | $11.1K | Sell |
740
-926
| -56% | -$13.9K | ﹤0.01% | 5688 |
|
|
2024
Q2 | $47.7K | Sell |
1,666
-1,080
| -39% | -$30.9K | ﹤0.01% | 4693 |
|
|
2024
Q1 | $80.2K | Sell |
2,746
-2,536
| -48% | -$74.1K | ﹤0.01% | 4390 |
|
|
2023
Q4 | $178K | Sell |
5,282
-676
| -11% | -$22.8K | ﹤0.01% | 4021 |
|
|
2023
Q3 | $183K | Buy |
5,958
+482
| +9% | +$14.8K | ﹤0.01% | 4060 |
|
|
2023
Q2 | $219K | Sell |
5,476
-524
| -9% | -$21K | ﹤0.01% | 3822 |
|
|
2023
Q1 | $245K | Sell |
6,000
-9,636
| -62% | -$393K | ﹤0.01% | 3710 |
|
|
2022
Q4 | $604K | Sell |
15,636
-719
| -4% | -$27.8K | ﹤0.01% | 2858 |
|
|
2022
Q3 | $868K | Buy |
16,355
+550
| +3% | +$29.2K | ﹤0.01% | 2366 |
|
|
2022
Q2 | $922K | Sell |
15,805
-7,310
| -32% | -$426K | ﹤0.01% | 2359 |
|
|
2022
Q1 | $1.76M | Buy |
23,115
+6,625
| +40% | +$505K | ﹤0.01% | 2032 |
|
|
2021
Q4 | $993K | Buy |
16,490
+10,191
| +162% | +$614K | ﹤0.01% | 2413 |
|
|
2021
Q3 | $353K | Buy |
6,299
+509
| +9% | +$28.5K | ﹤0.01% | 3383 |
|
|
2021
Q2 | $354K | Sell |
5,790
-50
| -0.9% | -$3.06K | ﹤0.01% | 3361 |
|
|
2021
Q1 | $410K | Sell |
5,840
-144
| -2% | -$10.1K | ﹤0.01% | 3087 |
|
|
2020
Q4 | $359K | Sell |
5,984
-122
| -2% | -$7.32K | ﹤0.01% | 2947 |
|
|
2020
Q3 | $367K | Buy |
6,106
+1,590
| +35% | +$95.6K | ﹤0.01% | 2711 |
|
|
2020
Q2 | $234K | Buy |
4,516
+509
| +13% | +$26.4K | ﹤0.01% | 2984 |
|
|
2020
Q1 | $135K | Buy |
+4,007
| New | +$135K | ﹤0.01% | 3227 |
|